Advertisement

Topics

Project SOAR-Mental Health Malawi: Depression and HIV Integration

2018-06-18 02:03:10 | BioPortfolio

Published on BioPortfolio: 2018-06-18T02:03:10-0400

Clinical Trials [2523 Associated Clinical Trials listed on BioPortfolio]

Perinatal Depression Treatment in a Pediatric Setting- Pilot Phase

The purpose of this project is to test whether a new model of collaborative care depression treatment adapted to the needs and preferences of low-income, urban mothers with perinatal depre...

Investigational TMS Treatment for Depression

This study is aimed to help us learn about the effects of Transcranial Magnetic Stimulation at the forehead versus the left side of the head for treatment of Treatment Resistant Depression...

Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression

This study will use measurements of depression symptoms and brain activity to determine what factors may influence an individual's response to treatment for depression.

Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)

This study will test a therapy for both helping people adhere to their HIV medication regimens and treating them for depression.

Measuring Quality of Decisions About Treatment of Depression

The purpose of this randomized controlled trial is to examine the impact of a patient decision aid on the quality of decisions about managing symptoms of depression. In particular, we will...

PubMed Articles [17736 Associated PubMed Articles listed on BioPortfolio]

Depression prevalence and treatment among older home health services users in the United States.

The purpose of this study is to provide a nationally representative estimate of the rates of depression and depression treatment, and to explore factors associated with receipt of depression treatment...

Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics.

Depression that does not respond to antidepressants is treatment-resistant depression (TRD). TRD definitions include assessments of treatment response, dose and duration, and implementing these defini...

Risk of Diabetes Hospitalization or Diabetes Drug Intensification in Patients With Depression and Diabetes Using Second-Generation Antipsychotics Compared to Other Depression Therapies.

Use of second-generation antipsychotics (SGAs) for treatment of depression has increased, and patients with depression and comorbid diabetes or cardiovascular disease are more likely to use SGAs than ...

Validity of the Maudsley Staging Method in Predicting Treatment-Resistant Depression Outcome Using the Netherlands Study of Depression and Anxiety.

We investigated if the degree of treatment resistance of depression, as measured by the Maudsley Staging Method (MSM), is predictive of a worse depression outcome by using a large naturalistic cohort ...

Cumulative Burden of Depression and All-Cause Mortality in Women Living with HIV.

Research linking depression to mortality among people living with HIV (PLWH) has largely focused on binary "always vs. never" characterizations of depression. However, depression is chronic, and is li...

Medical and Biotech [MESH] Definitions

Decompression external to the body, most often the slow lessening of external pressure on the whole body (especially in caisson workers, deep sea divers, and persons who ascend to great heights) to prevent DECOMPRESSION SICKNESS. It includes also sudden accidental decompression, but not surgical (local) decompression or decompression applied through body openings.

Depression in POSTPARTUM WOMEN, usually within four weeks after giving birth (PARTURITION). The degree of depression ranges from mild transient depression to neurotic or psychotic depressive disorders. (From DSM-IV, p386)

An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

A propylamine formed from the cyclization of the side chain of amphetamine. This monoamine oxidase inhibitor is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in panic and phobic disorders. (From AMA Drug Evaluations Annual, 1994, p311)

Depressive states usually of moderate intensity in contrast with major depression present in neurotic and psychotic disorders.

More From BioPortfolio on "Project SOAR-Mental Health Malawi: Depression and HIV Integration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial